Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura K Hummers

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Rheumatology (Oxford, England)|April 12, 2025
Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosisAli Y Ayla, Naveen R Kalavar, Mark Pimentel, et al.
Arthritis Care & Research|May 26, 2017
Association of Fibrosing Myopathy in Systemic Sclerosis and Higher MortalityJulie J Paik, Fredrick M Wigley, Ami A Shah, et al.
Rheumatology (Oxford, England)|October 7, 2024
Demographics and clinical features associated with abnormal small bowel motility in systemic sclerosisJenice X Cheah, Jamie Perin, Michael Hughes, et al.
Medicine|June 25, 2013
Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literatureAllan C Gelber, Rebecca L Manno, Ami A Shah, et al.
Pulmonary Circulation|January 17, 2017
Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosisZeling Cao, Stephen C Mathai, Laura K Hummers, et al.
Frontiers in Nuclear Medicine|June 16, 2025
<sup>18</sup>F-NaF PET/CT identifies muscular and subcutaneous calcifications in both dermatomyositis- and systemic sclerosis-related calcinosisCarrie Richardson, Mehrbod S Javadi, Ami A Shah, et al.
Arthritis Research & Therapy|January 11, 2022
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysisMichael Kreuter, Francesco Del Galdo, Corinna Miede, et al.
Current Cardiology Reports|January 4, 2025
Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical ImplicationsRyan Osgueritchian, Hoda Mombeini, Vivek P Jani, et al.
Annals of the Rheumatic Diseases|December 27, 2012
A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenonLaura K Hummers, Carin E Dugowson, Frederick J Dechow, et al.
Circulation. Cardiovascular Imaging|June 9, 2016
Unique Abnormalities in Right Ventricular Longitudinal Strain in Systemic Sclerosis PatientsMonica Mukherjee, Shang-En Chung, Von Khue Ton, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Rheumatology (Oxford, England)|April 12, 2025
Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosisAli Y Ayla, Naveen R Kalavar, Mark Pimentel, et al.
Arthritis Care & Research|May 26, 2017
Association of Fibrosing Myopathy in Systemic Sclerosis and Higher MortalityJulie J Paik, Fredrick M Wigley, Ami A Shah, et al.
Rheumatology (Oxford, England)|October 7, 2024
Demographics and clinical features associated with abnormal small bowel motility in systemic sclerosisJenice X Cheah, Jamie Perin, Michael Hughes, et al.
Medicine|June 25, 2013
Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literatureAllan C Gelber, Rebecca L Manno, Ami A Shah, et al.
Pulmonary Circulation|January 17, 2017
Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosisZeling Cao, Stephen C Mathai, Laura K Hummers, et al.
Frontiers in Nuclear Medicine|June 16, 2025
<sup>18</sup>F-NaF PET/CT identifies muscular and subcutaneous calcifications in both dermatomyositis- and systemic sclerosis-related calcinosisCarrie Richardson, Mehrbod S Javadi, Ami A Shah, et al.
Arthritis Research & Therapy|January 11, 2022
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysisMichael Kreuter, Francesco Del Galdo, Corinna Miede, et al.
Current Cardiology Reports|January 4, 2025
Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical ImplicationsRyan Osgueritchian, Hoda Mombeini, Vivek P Jani, et al.
Annals of the Rheumatic Diseases|December 27, 2012
A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenonLaura K Hummers, Carin E Dugowson, Frederick J Dechow, et al.
Circulation. Cardiovascular Imaging|June 9, 2016
Unique Abnormalities in Right Ventricular Longitudinal Strain in Systemic Sclerosis PatientsMonica Mukherjee, Shang-En Chung, Von Khue Ton, et al.
Pageof 14